The complications of obesity affect nearly every organ system. Treatment approaches include pharmacotherapy, modification of behavior and lifestyle, and surgery. Analysis of the root cause for each patient is essential.

Sitagliptin is an incretin mimetic that targets mainly postprandial glucose in the treatment of patients with type 2 diabetes mellitus. It provides a modest reduction in HbA1c and may be an option for certain patients who are not achieving established glycemic controls.

Because secondary hypertension can most often be linked to certain conditions and medications, treatment strategies focus on identifying and removing the pathologic or pharmacologic cause in order to restore normal hemostatic homeostasis and blood pressure control.

Upper respiratory tract infections are the most common acute illnesses in the general population. Pharmacists should be familiar with the etiology and potential treatments for these infections.

This article focuses on chronic heart failure and provides on overview of the disease, medication therapy management, and more.

Overuse and inappropriate use of antimicrobials have contributed to the development of resistance in both the inpatient and outpatient setting.

It is important for pharmacists to be aware of their responsibilities under the Medication Guide program.

This continuing education lesson reviews the new molecular entities (NMEs) approved by the Food & Drug Administration in 2007.

About one million people in the United States have chronic fatigue syndrome